Annual D&A
$125.10 M
-$18.20 M-12.70%
31 December 2023
Summary:
Emergent BioSolutions annual depreciation & amortization is currently $125.10 million, with the most recent change of -$18.20 million (-12.70%) on 31 December 2023. During the last 3 years, it has risen by +$10.60 million (+9.26%). EBS annual D&A is now -12.70% below its all-time high of $143.30 million, reached on 31 December 2022.EBS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$26.40 M
-$2.10 M-7.37%
30 September 2024
Summary:
Emergent BioSolutions quarterly depreciation & amortization is currently $26.40 million, with the most recent change of -$2.10 million (-7.37%) on 30 September 2024. Over the past year, it has dropped by -$1.60 million (-5.71%). EBS quarterly D&A is now -40.67% below its all-time high of $44.50 million, reached on 30 June 2022.EBS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$112.40 M
-$1.60 M-1.40%
30 September 2024
Summary:
Emergent BioSolutions TTM depreciation & amortization is currently $112.40 million, with the most recent change of -$1.60 million (-1.40%) on 30 September 2024. Over the past year, it has dropped by -$18.80 million (-14.33%). EBS TTM D&A is now -23.54% below its all-time high of $147.00 million, reached on 31 March 2023.EBS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.7% | -5.7% | -14.3% |
| 3 y3 years | +9.3% | -19.3% | -9.0% |
| 5 y5 years | +101.1% | -4.7% | +4.2% |
EBS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -12.7% | +9.3% | -40.7% | at low | -23.5% | at low |
| 5 y | 5 years | -12.7% | +101.1% | -40.7% | at low | -23.5% | +4.2% |
| alltime | all time | -12.7% | +6600.6% | -40.7% | +2342.2% | -23.5% | +9282.3% |
Emergent BioSolutions Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $26.40 M(-7.4%) | $112.40 M(-1.4%) |
| June 2024 | - | $28.50 M(+2.2%) | $114.00 M(-3.7%) |
| Mar 2024 | - | $27.90 M(-5.7%) | $118.40 M(-5.4%) |
| Dec 2023 | $125.10 M(-12.7%) | $29.60 M(+5.7%) | $125.10 M(-4.6%) |
| Sept 2023 | - | $28.00 M(-14.9%) | $131.20 M(-3.1%) |
| June 2023 | - | $32.90 M(-4.9%) | $135.40 M(-7.9%) |
| Mar 2023 | - | $34.60 M(-3.1%) | $147.00 M(+2.6%) |
| Dec 2022 | $143.30 M(+15.8%) | $35.70 M(+10.9%) | $143.30 M(+4.8%) |
| Sept 2022 | - | $32.20 M(-27.6%) | $136.80 M(-0.4%) |
| June 2022 | - | $44.50 M(+44.0%) | $137.30 M(+9.0%) |
| Mar 2022 | - | $30.90 M(+5.8%) | $126.00 M(+1.8%) |
| Dec 2021 | $123.80 M(+8.1%) | $29.20 M(-10.7%) | $123.80 M(+0.2%) |
| Sept 2021 | - | $32.70 M(-1.5%) | $123.50 M(+3.3%) |
| June 2021 | - | $33.20 M(+15.7%) | $119.60 M(+4.0%) |
| Mar 2021 | - | $28.70 M(-0.7%) | $115.00 M(+0.4%) |
| Dec 2020 | $114.50 M(+3.4%) | $28.90 M(+0.3%) | $114.50 M(+0.9%) |
| Sept 2020 | - | $28.80 M(+0.7%) | $113.50 M(+1.0%) |
| June 2020 | - | $28.60 M(+1.4%) | $112.40 M(+0.1%) |
| Mar 2020 | - | $28.20 M(+1.1%) | $112.30 M(+1.4%) |
| Dec 2019 | $110.70 M(+78.0%) | $27.90 M(+0.7%) | $110.70 M(+2.6%) |
| Sept 2019 | - | $27.70 M(-2.8%) | $107.90 M(+16.5%) |
| June 2019 | - | $28.50 M(+7.1%) | $92.60 M(+21.0%) |
| Mar 2019 | - | $26.60 M(+6.0%) | $76.50 M(+23.0%) |
| Dec 2018 | $62.20 M(+46.0%) | $25.10 M(+102.4%) | $62.20 M(+24.9%) |
| Sept 2018 | - | $12.40 M(0.0%) | $49.80 M(+5.5%) |
| June 2018 | - | $12.40 M(+0.8%) | $47.20 M(+5.5%) |
| Mar 2018 | - | $12.30 M(-3.2%) | $44.73 M(+5.0%) |
| Dec 2017 | $42.60 M(+11.5%) | $12.70 M(+29.6%) | $42.60 M(+6.6%) |
| Sept 2017 | - | $9.80 M(-1.3%) | $39.94 M(-1.4%) |
| June 2017 | - | $9.93 M(-2.3%) | $40.53 M(+2.5%) |
| Mar 2017 | - | $10.17 M(+1.2%) | $39.53 M(+3.5%) |
| Dec 2016 | $38.20 M(+8.1%) | $10.04 M(-3.3%) | $38.20 M(+1.5%) |
| Sept 2016 | - | $10.38 M(+16.3%) | $37.63 M(+5.1%) |
| June 2016 | - | $8.93 M(+1.0%) | $35.81 M(+0.5%) |
| Mar 2016 | - | $8.84 M(-6.7%) | $35.64 M(+0.9%) |
| Dec 2015 | $35.34 M | $9.48 M(+10.7%) | $35.34 M(+3.8%) |
| Sept 2015 | - | $8.56 M(-2.3%) | $34.03 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $8.77 M(+2.7%) | $34.46 M(+0.9%) |
| Mar 2015 | - | $8.53 M(+4.5%) | $34.15 M(+5.2%) |
| Dec 2014 | $32.45 M(+71.2%) | $8.17 M(-9.2%) | $32.45 M(+9.3%) |
| Sept 2014 | - | $8.99 M(+6.3%) | $29.70 M(+14.7%) |
| June 2014 | - | $8.46 M(+23.8%) | $25.88 M(+19.6%) |
| Mar 2014 | - | $6.83 M(+26.3%) | $21.63 M(+14.1%) |
| Dec 2013 | $18.96 M(+69.3%) | $5.41 M(+4.6%) | $18.96 M(+11.1%) |
| Sept 2013 | - | $5.17 M(+23.0%) | $17.07 M(+16.4%) |
| June 2013 | - | $4.21 M(+1.1%) | $14.66 M(+12.9%) |
| Mar 2013 | - | $4.16 M(+18.3%) | $12.99 M(+16.0%) |
| Dec 2012 | $11.20 M(+19.7%) | $3.52 M(+27.0%) | $11.20 M(+10.8%) |
| Sept 2012 | - | $2.77 M(+9.2%) | $10.11 M(+3.7%) |
| June 2012 | - | $2.54 M(+6.9%) | $9.75 M(+2.7%) |
| Mar 2012 | - | $2.37 M(-2.3%) | $9.49 M(+1.5%) |
| Dec 2011 | $9.36 M(+56.2%) | $2.43 M(+0.7%) | $9.36 M(+5.2%) |
| Sept 2011 | - | $2.41 M(+5.8%) | $8.90 M(+13.2%) |
| June 2011 | - | $2.28 M(+2.0%) | $7.86 M(+13.4%) |
| Mar 2011 | - | $2.23 M(+13.5%) | $6.93 M(+15.7%) |
| Dec 2010 | $5.99 M(+19.8%) | $1.97 M(+43.4%) | $5.99 M(+12.1%) |
| Sept 2010 | - | $1.37 M(+1.8%) | $5.34 M(+4.0%) |
| June 2010 | - | $1.35 M(+4.2%) | $5.14 M(+2.1%) |
| Mar 2010 | - | $1.30 M(-2.0%) | $5.03 M(+0.7%) |
| Dec 2009 | $5.00 M(+0.7%) | $1.32 M(+13.0%) | $5.00 M(-1.9%) |
| Sept 2009 | - | $1.17 M(-6.0%) | $5.09 M(-2.2%) |
| June 2009 | - | $1.25 M(-1.3%) | $5.21 M(+1.2%) |
| Mar 2009 | - | $1.26 M(-10.9%) | $5.14 M(+3.6%) |
| Dec 2008 | $4.96 M(+3.1%) | $1.42 M(+10.3%) | $4.96 M(+4.1%) |
| Sept 2008 | - | $1.28 M(+8.8%) | $4.77 M(+0.4%) |
| June 2008 | - | $1.18 M(+9.3%) | $4.75 M(+1.0%) |
| Mar 2008 | - | $1.08 M(-11.4%) | $4.70 M(-2.4%) |
| Dec 2007 | $4.82 M(+2.2%) | $1.22 M(-3.6%) | $4.82 M(+33.9%) |
| Sept 2007 | - | $1.26 M(+11.6%) | $3.60 M(+54.2%) |
| June 2007 | - | $1.13 M(-5.3%) | $2.33 M(+94.7%) |
| Mar 2007 | - | $1.20 M | $1.20 M |
| Dec 2006 | $4.71 M(+32.9%) | - | - |
| Dec 2005 | $3.55 M(+90.1%) | - | - |
| Dec 2004 | $1.87 M | - | - |
FAQ
- What is Emergent BioSolutions annual depreciation & amortization?
- What is the all time high annual D&A for Emergent BioSolutions?
- What is Emergent BioSolutions annual D&A year-on-year change?
- What is Emergent BioSolutions quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly D&A year-on-year change?
- What is Emergent BioSolutions TTM depreciation & amortization?
- What is the all time high TTM D&A for Emergent BioSolutions?
- What is Emergent BioSolutions TTM D&A year-on-year change?
What is Emergent BioSolutions annual depreciation & amortization?
The current annual D&A of EBS is $125.10 M
What is the all time high annual D&A for Emergent BioSolutions?
Emergent BioSolutions all-time high annual depreciation & amortization is $143.30 M
What is Emergent BioSolutions annual D&A year-on-year change?
Over the past year, EBS annual depreciation & amortization has changed by -$18.20 M (-12.70%)
What is Emergent BioSolutions quarterly depreciation & amortization?
The current quarterly D&A of EBS is $26.40 M
What is the all time high quarterly D&A for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly depreciation & amortization is $44.50 M
What is Emergent BioSolutions quarterly D&A year-on-year change?
Over the past year, EBS quarterly depreciation & amortization has changed by -$1.60 M (-5.71%)
What is Emergent BioSolutions TTM depreciation & amortization?
The current TTM D&A of EBS is $112.40 M
What is the all time high TTM D&A for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM depreciation & amortization is $147.00 M
What is Emergent BioSolutions TTM D&A year-on-year change?
Over the past year, EBS TTM depreciation & amortization has changed by -$18.80 M (-14.33%)